Literature DB >> 25031509

Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece.

Tz Kotrotsiou1, M Exindari1, E Diza1, G Gioula1, A Melidou1, K Kaplanis2, N Malisiovas1.   

Abstract

AIM: This study attends to determine the prevalence and the antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece. MATERIALS-
METHODS: A total of 347 cervical smears were divided into 5 groups according to age. Samples were cultured, Ureaplasma urealyticum isolation was confirmed by the detection of the urease gene and the antimicrobial susceptibility of the isolates to 9 commercially available antibiotics was determined.
RESULTS: Fifty-six (16.13%) samples were found positive. Women >60 years old were rarely infected. Only 9 (16.07%) isolates were susceptible to all antimicrobials tested. Thirteen isolates were resistant and 34 intermediately resistant to ciprofloxacin, two resistant and 29 intermediately resistant to ofloxacin, three intermediately resistant to macrolides, while all were susceptible to tetracyclines.
CONCLUSIONS: In Northern Greece, 16.13% of asymptomatic women seem to be carriers of Ureaplasma urealyticum mostly in reproductive ages. Almost no resistance to macrolides and tetracyclines has been noticed, while most of the isolates present resistance or moderate sensitivity to quinolones.

Entities:  

Keywords:  Northern Greece; Ureaplasma urealyticum; asymptomatic; prevalence; susceptibility; women

Year:  2013        PMID: 25031509      PMCID: PMC4097411     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  18 in total

1.  DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.

Authors:  C M Bébéar; H Renaudin; A Charron; M Clerc; S Pereyre; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

2.  Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.

Authors:  Xinyou Xie; Jun Zhang
Journal:  FEMS Microbiol Lett       Date:  2006-06       Impact factor: 2.742

3.  Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum among students in northern Norway.

Authors:  A J Jensen; C R Kleveland; A Moghaddam; H Haaheim; S O Hjelmevoll; V Skogen
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03-26       Impact factor: 6.166

4.  Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.

Authors:  S Pereyre; M Métifiot; C Cazanave; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Int J Antimicrob Agents       Date:  2006-12-28       Impact factor: 5.283

Review 5.  Ureaplasma species: role in diseases of prematurity.

Authors:  Rose M Viscardi
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

6.  Fluoroquinolone resistance in Ureaplasma parvum in the United States.

Authors:  Lynn Duffy; John Glass; Geraldine Hall; Robin Avery; Raymond Rackley; Scott Peterson; Ken Waites
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

Review 7.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease.

Authors:  M Abele-Horn; C Wolff; P Dressel; F Pfaff; A Zimmermann
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

9.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

10.  Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum.

Authors:  Meng Dongya; Xue Wencheng; Ma Xiaobo; Wang Lu
Journal:  Microb Drug Resist       Date:  2008-09       Impact factor: 3.431

View more
  3 in total

1.  The role of Ureaplasma parvum serovar-3 or serovar-14 infection in female patients with chronic micturition urethral pain and recurrent microscopic hematuria.

Authors:  Moon Seong Kim; Dong Hyun Lee; Tae Jin Kim; Jong Jin Oh; Seung Ryeol Rhee; Dong Soo Park; Young Dong Yu
Journal:  Transl Androl Urol       Date:  2021-01

2.  Sequence analysis reveals asymptomatic infection with Mycoplasma hominis and Ureaplasma urealyticum possibly leads to infertility in females: A cross-sectional study.

Authors:  Chinyere Charity Ezeanya-Bakpa; Nneka Regina Agbakoba; Charolette Blanche Oguejiofor; Ifeoma Bessie Enweani-Nwokelo
Journal:  Int J Reprod Biomed       Date:  2021-12-13

3.  The Prevalence of Sexually Transmitted Infections and Sociosexual Behaviors in the South Korean Military Before and During the COVID-19 Pandemic.

Authors:  Tae Hoon Oh; Jong Hyun Baeck; Seung Ryeol Lee; Dong Soo Park; Young Dong Yu
Journal:  Mil Med       Date:  2021-11-13       Impact factor: 1.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.